NCT04881578View on ClinicalTrials.gov

Atrial Fibrillation Before and After Patent Foramen Ovale Closure Study

Active, not recruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

March 31, 2021

Primary Completion Date

November 30, 2027

Study Completion Date

November 30, 2027

Conditions
Cryptogenic StrokeForamen Ovale, PatentAtrial Fibrillation
Interventions
OTHER

continuous cardiac monitoring before and after transcatheter PFO closure

Data will be assessed from patients with cryptogenic stroke and planned PFO occlusion who undergo the contemporary ICM protocols to search for silent AF

Trial Locations (6)

4053

University Hospital Basel, Heart Center, Basel

4500

Bürgerspital Solothurn Cardiology, Solothurn

8006

University Hospital Zürich Cardiology, Zurich

8063

Stadtspital Triemli, Zurich

9007

Cantonal Hospital St.Gallen Cardiology, Sankt Gallen

Unknown

University Hospital Bern Inselspital Cardiology, Bern

All Listed Sponsors
lead

Raban Jeger

OTHER